Related Experiment Video
Updated: Dec 17, 2025

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
7.1K
Pervasive lesion segregation shapes cancer genome evolution
Sarah J Aitken1,2,3, Craig J Anderson4, Frances Connor1
1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Nature
|June 26, 2020
Summary
Most DNA lesions persist across cell divisions, leading to chromosome-scale mutation patterns. This explains how mutations generate genetic diversity and impacts cancer genome evolution.
Area of Science:
- Genetics
- Cancer Biology
- Genomics
Background:
- Cancer develops from genetic mutations and clonal expansion.
- The fate of DNA lesions and their impact on mutation patterns over cell cycles are not fully understood.
Purpose of the Study:
- To investigate the fate of mutagenic DNA lesions across multiple cell cycles.
- To understand how unrepaired DNA lesions contribute to mutation patterns and genetic diversity in cancer.
Main Methods:
- Analysis of mutagen-induced mouse liver tumors.
- Characterization of DNA lesion segregation and subsequent mutations.
- Examination of DNA replication across persistent lesions.
Main Results:
- Most mutagenic DNA lesions are not repaired in a single cell cycle but segregate into daughter cells.
- This segregation leads to chromosome-scale phasing of mutations.
- Replication across persistent lesions generates multiallelic and combinatorial genetic diversity.
- Lesion phasing allows precise measurement of repair bias, selection, and sister-chromatid exchange.
Conclusions:
- DNA lesion segregation is a fundamental process influencing mutation patterns across multiple cell generations.
- This mechanism contributes significantly to the genetic diversity observed in cancer genomes.
- Lesion segregation is a common feature of various mutagens, including UV light and chemotherapy agents, with broad implications for cancer evolution.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
14.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Adaptive Mechanisms in Cancer Cells
6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K

